Altis Biosystems, which specializes in using human intestinal tissue cells to test novel drug therapies, has announced the recipient of its second Research Funding Initiative. Here are the details.
Read More
The Winston-Salem-headquartered Plakous Therapeutics has landed $310,000 in funding from NC Biotechnology Center programs.
Read More
Plakous Therapeutics won the 2022 NC BIONEER Venture Challenge, the first statewide challenge led by the North Carolina Biotechnology Center.
Read More
Plakous is developing human placenta-derived regenerative therapies, initially focused on Protego-PD, a platform product to treat a devastating and costly disease of premature babies called necrotizing enterocolitis (NEC).
Read MoreThe Council for Entrepreneurial Development’s annual Life Science Conference will feature a host of new and returning companies as well as many first-time participants. And today six of the first-time firms are profiled in the first of a series that will feature these ventures ahead of the two-day event
Read More
